West Pharmaceutical Services (WST) Invested Capital (2009 - 2026)

West Pharmaceutical Services has disclosed Invested Capital across 18 years of filings, most recently posting $3.2 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $3.2 billion, up 10.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 billion (up 10.66% YoY), and the FY2025 annual result was $3.4 billion, up 17.12% from the prior year.
• Invested Capital came in at $3.2 billion for Q1 2026 at West Pharmaceutical Services, down from $3.4 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $3.4 billion in Q4 2025 to a low of $2.6 billion in Q1 2022.
• The 5-year median for Invested Capital is $3.0 billion (2023), against an average of $3.0 billion.
• Across the five-year window, Invested Capital increased 23.76% in 2022 and declined 6.57% in 2024, its largest moves.
• West Pharmaceutical Services' Invested Capital stood at $2.9 billion in 2022, then grew by 6.7% to $3.1 billion in 2023, then decreased by 6.57% to $2.9 billion in 2024, then advanced by 17.12% to $3.4 billion in 2025, then decreased by 5.49% to $3.2 billion in 2026.
• The last three Invested Capital figures came in at $3.2 billion (Q1 2026), $3.4 billion (Q4 2025), and $3.3 billion (Q3 2025), per Business Quant data.